Deane and colleagues identified a highly specific small molecule, FPS-ZM1, that blocks Aβ binding to the V-type extracellular domain of RAGE, thus preventing Aβ accumulation and Aβ-induced cellular toxicity in the APP (APPsw∕0) mouse model of AD (Deane et al., 2012). This evidence concerns the gene APP and Alzheimer disease.